类固醇、甾体|Steroids-毕得医药

关于我们|联系我们 400-600-5915|sales@picasso-e.com

登录 | 注册批量下单

搜索购物车会员中心

类固醇是一种具有生物活性的有机化合物，有四个环排列在特定的分子结构中。甾体具有两种主要的生物学功能:作为改变膜流动性的细胞膜的重要组成部分;作为信号分子。所有的类固醇都是从甾醇、羊毛甾醇(opisthokonts)或环芳烃醇(植物)的细胞中制造出来的。

(R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-二羟基-10,13-二甲基十六氢-1H-环戊基[a]菲-17-基)戊酸: BJS2306975128-13-298%; ￥88.005g

(2S,5S,5aR,7aS,7bR,9aR,11S,13aR,13bR,15bS)-11-Hydroxy-2,5a,7a,7b,10,10,13a-heptamethyl-1,5,5a,6,7,7a,7b,8,9,9a,10,11,12,13,13a,13b,14,15b-octadecahydro-2,5-methanochryseno[2,1-c]oxepin-3(2H)-one (2S,5S,5aR,7aS,7bR,9aR,11S,13aR,13bR,15bS)-11-羟基-2,5a,7a,7b,10,10,13a-七甲基-1,5,5a,6,7,7a,7b,8,9,9a,10,11,12,13,13a,13b,14,15b-十八氢-2,5-甲基四苯[2,1-c]氧杂环己烷-3(2H)-酮: 84104-71-298+%; ￥863.0010mg

(6aR,6bS,8aS,8bS,9aR,10aS,10bR)-8b-Acetyl-6a,8a-dimethyl-5,6,6a,6b,7,8,8a,8b,9a,10,10a,10b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-b]oxiren-4(2H)-one 16,17-环氧黄体酮: BJS30283041097-51-497%; ￥527.00100g

(2'R,4S,5'R,6aR,6bS,8aS,8bR,9S,11aS,12aS,12bS)-5',6a,8a,9-Tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-ol (2'R,4S,5'R,6aR,6bS,8aS,8bR,9S,11aS,12aS,12bS)-5',6a,8a,9-四甲基-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-二十氢螺[萘并[2',1':4,5]茚并[2,1,1-b]呋喃-10,2'吡喃]-4-醇: BJS4741614512-04-998%; ￥61.005g

(8R,9S,10R,13S,14S,17R)-17-Acetyl-17-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one (8R,9S,10R,13S,14S,17R)-17-乙酰基-17-羟基-10,13-二甲基-6,7,8,9,10,11,12,13,14,15,16,17-十二氢-1H-环戊烷并[a]菲-3(2H)-酮: BJS452745268-96-298%; ￥61.005g

Bardoxolone methyl 2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯: BJS3662620218600-53-498%; ￥294.0025mg

7-Ketocholesterol 胆甾-3-羟基-5-烯-7-酮: BJS0629748566-28-998%; ￥4595.0025mg

(1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-(((2R,3S,4S,5S,6R)-4-Amino-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-(((2R,3S,4S,5S,6R)-4-氨基-3,5-二羟基-6-甲基四氢-2H-吡喃-2-基)氧基)-1,3,26-三羟基-12-甲基-10-氧代-6,11,28-三氧三环[22.3.1.05,7 ] 二十八烷-8,14,16,18,20-戊烯-25-羧酸: BJS33937467681-93-898%; ￥468.0010g

(3S,8S,9S,10R,13R,14S,17R)-17-((2R,5R)-5-Ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol (3S,8S,9S,10R,13R,14S,17R)-17-((2R,5R)-5-乙基-6-甲基庚-2-基)-10,13-二甲基-2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊烷并[a]菲-3-醇: BJS959395083-46-575+%; ￥798.00100g

(3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-Octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-ol (3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-八甲基-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-二十氢苉-3-醇: BJS3076626638-95-997%; ￥10849.0010mg

(2S,4aR,4bS,6aS,7aS,8aS,8bS,8cR,8dR,9aR,9bR)-2,9b-Dihydroxy-4a,6a-dimethylhexadecahydro-1H-cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthren-7(7aH)-one (2S,4aR,4bS,6aS,7aS,8aS,8bS,8cR,8dR,9aR,9bR)-2.9b-二羟基-4a,6a-二甲基十八烷基-7H-环丙烷[4,5]环戊[1,2-a]环丙烷[l]菲蒽7-酮: BJS328102582543-16-695%; ￥452.001g

(R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-乙基-3,7-二羟基-10,13-二甲基十六氢-1H-环戊二烯并[a]菲-17-基)戊酸: BJS7915636459789-99-298%; ￥569.001g

(3S,5R,8S,9S,10R,13R,14S,17R)-5-Hydroxy-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl methanesulfonate (3S,5R,8S,9S,10R,13R,14S,17R)-5-羟基-10,13-二甲基-17-((R)-6-甲基庚烷-2-基)十六氢-1H-环戊二烯并[a]菲-3-基甲磺酸酯: BJS599002463015-73-695+%; ￥暂无

(8R,9S,13S,14S,17S)-2-Methoxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol (8R,9S,13S,14S,17S)-2-甲氧基-13-甲基-7,8,9,11,12,13,14,15,16,17-十氢-6H-环戊二烯并[a]菲-3,17-二醇: BJS1911653362-07-298%; ￥815.00100mg

1